BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125]
URL: https://www.wjgnet.com/1007-9327/full/v12/i7/1125.htm
Number Citing Articles
1
Joseph R Volpicelli, Miriam Fenton. Sustained-release naltrexone formulations for the treatment of alcohol and opioid dependenceFuture Neurology 2006; 1(4): 389 doi: 10.2217/14796708.1.4.389
2
Babina Sanjel, Won-Sik Shim. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A reviewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165958 doi: 10.1016/j.bbadis.2020.165958
3
Sonja Ständer, Elke Weisshaar, Thomas A. Luger. Neurophysiological and neurochemical basis of modern pruritus treatmentExperimental Dermatology 2008; 17(3): 161 doi: 10.1111/j.1600-0625.2007.00664.x
4
Carolyn Stull, Michael J. Lavery, Gil Yosipovitch. Advances in therapeutic strategies for the treatment of pruritusExpert Opinion on Pharmacotherapy 2016; 17(5): 671 doi: 10.1517/14656566.2016.1127355
5
Kimberly A. Bower, Gerit D. Mulder, Anke Reineke, Shireen V. Guide. Textbook of Interdisciplinary Pediatric Palliative Care2011; : 350 doi: 10.1016/B978-1-4377-0262-0.00035-9
6
Annabel Maruani, Mahtab Samimi, Gérard Lorette. Les prurigosLa Presse Médicale 2009; 38(7-8): 1099 doi: 10.1016/j.lpm.2008.10.014
7
Andreas Binder, Jana Koroschetz, Ralf Baron. Disease mechanisms in neuropathic itchNature Clinical Practice Neurology 2008; 4(6): 329 doi: 10.1038/ncpneuro0806
8
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pruritus in Chronic Cholestatic Liver DiseaseClinics in Liver Disease 2012; 16(2): 331 doi: 10.1016/j.cld.2012.03.010
9
Juan Pablo Aristizábal Linares, Lester Andrade Almario. Eficacia de la naltrexona en el tratamiento de prurito severoRevista Colombiana de Anestesiología 2011; 39(2): 251 doi: 10.5554/rca.v39i2.91
10
Roger W. Chapman, Kate D. Williamson. Crohn's Disease and Ulcerative Colitis2017; : 531 doi: 10.1007/978-3-319-33703-6_52
11
Kazuto Tajiri, Yukihiro Shimizu. Recent advances in the management of pruritus in chronic liver diseasesWorld Journal of Gastroenterology 2017; 23(19): 3418-3426 doi: 10.3748/wjg.v23.i19.3418
12
Mariusz Sikora, Adriana Rakowska, Małgorzata Olszewska, Lidia Rudnicka. The Use of Naltrexone in Dermatology. Current Evidence and Future DirectionsCurrent Drug Targets 2019; 20(10): 1058 doi: 10.2174/1389450120666190318121122
13
Nora V. Bergasa. Update on the Treatment of the Pruritus of CholestasisClinics in Liver Disease 2008; 12(1): 219 doi: 10.1016/j.cld.2007.11.009
14
Santiago Medina Ramírez, Ana Milena Sánchez, Francisco Gómez Oquendo. Sugammadex en un paciente con insuficiencia renal crónicaRevista Colombiana de Anestesiología 2011; 39(3): 433 doi: 10.5554/rca.v39i3.219
15
Andreas E. Kremer, Ronald P.J. Oude Elferink, Ulrich Beuers. Pathophysiology and current management of pruritus in liver diseaseClinics and Research in Hepatology and Gastroenterology 2011; 35(2): 89 doi: 10.1016/j.clinre.2010.10.007
16
Nora V. Bergasa. Pruritus in Primary Biliary Cirrhosis: Pathogenesis and TherapyClinics in Liver Disease 2008; 12(2): 385 doi: 10.1016/j.cld.2008.02.013
17
Keith D. Lindor, M. Eric Gershwin, Raoul Poupon, Marshall Kaplan, Nora V. Bergasa, E. Jenny Heathcote. Primary biliary cirrhosisHepatology 2009; 50(1): 291 doi: 10.1002/hep.22906
18
Sarah Dillon, Joseph D. Tobias. Ondansetron to Treat Pruritus Due to Cholestatic JaundiceThe Journal of Pediatric Pharmacology and Therapeutics 2013; 18(3): 241 doi: 10.5863/1551-6776-18.3.241
19
Nora V. Bergasa. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these yearsMedical Hypotheses 2018; 110: 86 doi: 10.1016/j.mehy.2017.11.002
20
Parth Patel, Keshav Patel, Karan Pandher, Ruqiya Shama Tareen. The Role of Psychiatric, Analgesic, and Antiepileptic Medications in Chronic PruritusCureus 2021;  doi: 10.7759/cureus.17260
21
Joel E. Schlosburg, Dale L. Boger, Benjamin F. Cravatt, Aron H. Lichtman. Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for PruritusJournal of Pharmacology and Experimental Therapeutics 2009; 329(1): 314 doi: 10.1124/jpet.108.150136
22
Atsuki Yamamoto, Shoji Kuyama, Chiaki Kamei, Yukio Sugimoto. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in miceEuropean Journal of Pharmacology 2010; 627(1-3): 162 doi: 10.1016/j.ejphar.2009.10.066
23
Emilie Javelle, Philippe Paule, Yves Chabrillat, Edward Lightburn, Thierry Coton, Jean-Jacques Morand. Un prurit traité par implantation d’un pacemakerLa Presse Médicale 2011; 40(9): 885 doi: 10.1016/j.lpm.2011.03.003
24
Carola Xander, Joerg J Meerpohl, Daniel Galandi, Sabine Buroh, Guido Schwarzer, Gerd Antes, Gerhild Becker, Carola Xander. Cochrane Database of Systematic Reviews2013;  doi: 10.1002/14651858.CD008320.pub2
25
Nora V. Bergasa. Cirrhosis: A practical guide to management2015; : 291 doi: 10.1002/9781118412640.ch26
26
Tejesh Patel, Gil Yosipovitch. Therapy of pruritusExpert Opinion on Pharmacotherapy 2010; 11(10): 1673 doi: 10.1517/14656566.2010.484420
27
Andrea A. Gossard, Keith D. Lindor. Practical Gastroenterology and Hepatology: Liver and Biliary Disease2010; : 87 doi: 10.1002/9781444325249.ch10
28
Puneeta Tandon, Brian H. Rowe, Ben Vandermeer, Vincent G. Bain. The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated PruritusThe American Journal of Gastroenterology 2007; 102(7): 1528 doi: 10.1111/j.1572-0241.2007.01200.x
29
Nora V. Bergasa, Deewan Deewan. Pruritus2010; : 289 doi: 10.1007/978-1-84882-322-8_45
30
Sonja Ständer, Thomas A. Luger. Therapy of Skin Diseases2010; : 235 doi: 10.1007/978-3-540-78814-0_24
31
Hirsh D. Trivedi, Blanca Lizaola, Elliot B. Tapper, Alan Bonder. Management of Pruritus in Primary Biliary Cholangitis: A Narrative ReviewThe American Journal of Medicine 2017; 130(6): 744.e1 doi: 10.1016/j.amjmed.2017.01.037
32
Waldemar Siemens, Carola Xander, Joerg J Meerpohl, Sabine Buroh, Gerd Antes, Guido Schwarzer, Gerhild Becker. Pharmacological interventions for pruritus in adult palliative care patientsCochrane Database of Systematic Reviews 2016; 2016(11) doi: 10.1002/14651858.CD008320.pub3
33
Negar Faramarzi, Ata Abbasi, Seyed M Tavangar, Marjan Mazouchi, Ahmad R Dehpour. Opioid receptor antagonist promotes angiogenesis in bile duct ligated ratsJournal of Gastroenterology and Hepatology 2009; 24(7): 1226 doi: 10.1111/j.1440-1746.2009.05794.x
34
Stephani L. Stancil, Susan Abdel-Rahman, Jon Wagner. Developmental Considerations for the Use of Naltrexone in Children and AdolescentsThe Journal of Pediatric Pharmacology and Therapeutics 2021; 26(7): 675 doi: 10.5863/1551-6776-26.7.675
35
Fatima Isa, Grace M. Turner, Geetinder Kaur, Derek Kyte, Anita Slade, Tanya Pankhurst, Larissa Kerecuk, Thomas Keeley, James Ferguson, Melanie Calvert. Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic reviewHealth and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0951-6
36
Andreas E. Kremer. What are new treatment concepts in systemic itch?Experimental Dermatology 2019; 28(12): 1485 doi: 10.1111/exd.14024
37
Nora V. Bergasa. Opiate Receptors and Antagonists2009; : 551 doi: 10.1007/978-1-59745-197-0_29
38
Andreas E. Kremer, Ronald P. J. Oude-Elferink, Ulrich Beuers. Pruritus2010; : 177 doi: 10.1007/978-1-84882-322-8_28
39
Jacqueline A. G. M. Langedijk, Ulrich H. Beuers, Ronald P. J. Oude Elferink. Cholestasis-Associated Pruritus and Its PruritogensFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.639674
40
Richard J. Bodnar. Endogenous opiates and behavior: 2006Peptides 2007; 28(12): 2435 doi: 10.1016/j.peptides.2007.09.002
41
John Halliday, Roger W. Chapman. Crohn's Disease and Ulcerative Colitis2012; : 579 doi: 10.1007/978-1-4614-0998-4_47
42
Sombat Treeprasertsuk, Udomsak Silachamroon, Srivicha Krudsood, Arun Huntrup, Plengsakoon Suwannakudt, Suparp Vannaphan, Polrat Wilairatana. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundiceJournal of Gastroenterology and Hepatology 2010; 25(2): 362 doi: 10.1111/j.1440-1746.2009.06007.x
43
Ahmad H. Ali, Elizabeth J. Carey, Keith D. Lindor. Liver Disorders2017; : 251 doi: 10.1007/978-3-319-30103-7_16
44
Ngoc Quan Phan, Jeffrey D. Bernhard, Thomas A. Luger, Sonja Ständer. Antipruritic treatment with systemic μ-opioid receptor antagonists: A reviewJournal of the American Academy of Dermatology 2010; 63(4): 680 doi: 10.1016/j.jaad.2009.08.052
45
Fay Louise Murray-Brown. Naltrexone for cholestatic itch: a systematic reviewBMJ Supportive & Palliative Care 2021; 11(2): 217 doi: 10.1136/bmjspcare-2020-002801
46
Elsemieke de Vries, Ruth Bolier, Jorn Goet, Albert Parés, Jef Verbeek, Marleen de Vree, Joost Drenth, Karel van Erpecum, Karin van Nieuwkerk, Frans van der Heide, Nahid Mostafavi, Jeltje Helder, Cyriel Ponsioen, Ronald Oude Elferink, Henk van Buuren, Ulrich Beuers. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled TrialGastroenterology 2021; 160(3): 734 doi: 10.1053/j.gastro.2020.10.001
47
Wiebke Pirschel, Andreas E. Kremer. Pruritus2016; : 253 doi: 10.1007/978-3-319-33142-3_34
48
Andreas E. Kremer, Jamison Feramisco, Peter W. Reeh, Ulrich Beuers, Ronald P.J. Oude Elferink. Receptors, cells and circuits involved in pruritus of systemic disordersBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014; 1842(7): 869 doi: 10.1016/j.bbadis.2014.02.007